Summary
Oscillation of cyclic AMP and in the activity ratio of cyclic AMP-dependent protein kinase and of glycogen phosphorylase with the cardiac cycle were demonstrated in the canine heart in situ. For tissue sampling an ECG (R-wave)-triggered, automatically working push-freeze-drill apparatus was developed which allows intraventricular cryobiopsies from the left ventricular muscle of anaesthetized open-chest dogs. The nucleotide cyclic AMP oscillated with the cardiac cycle during normal working condition, the higher cyclic AMP level occuring during systole. Cyclic GMP was assayed to be without oscillatory changes during the contraction-relaxation cycle. The rise in the activity ratio of protein kinase was found to coincide with the maximum in the level of cyclic AMP. Propranolol pretreatment prevents the transient in the level of the nucleotide as well as in the activity ratio of the kinase indicating i) a causal relationship between these changes and ii) a neurohumoral, beat-to-beat regulation by catecholamines released from the sympathetic nerve endings within the heart. Contrary the activity ratio of phosphorylase retains its transient changes during the cardiac cycle in the presence of propranolol, indicating a Ca-mediated activation of phosphorlase kinase during the contraction process.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wier WG: Calcium transients during excitation-contraction coupling in mammalian heart: Aequorin signals of canine purkinje fibers. Sciences 207: 1085–1087, 1980
Toyo-Oka T, Nagayama K, Umeda M, Eguchi K, Hosada S: Rhythmic change of myocardial phosphate metabolite content in cardiac cycle observed by depth-selected, ECG-gated in vivo 31-NMR spectroscopy. Biochim Biophys Res Commun 135: 808–815, 1986
Thompson CT, Rubio R, Berne RM: Changes in adenosine and glycogen phosphorylase activity during the cardiac cycle. Amer J Physiol 238: H389-H398, 1980
Balaban RS: The study of cardiac energitics in vivo using nuclear magnetic resonance. J Mol Cell Cardiol 20 Suppl IV, p 11, 1988
Wollenberger A, Babskii E, Krause EG, Genz S, Blohm D, Bogdanowa E: Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle. Biochem Biophys Res Commun 55: 446–452, 1973
Krause EG, Bartel S, Freier W, Warbanow W, Gerber K, Ludecke J, Obst D: Oscillation of cyclic AMP with the heart cycle of the canine myocardium in situ. Biomed Biochim Acta 45: S205-S210, 1986
Brooker G: Implications of cyclic nucleotide oscillations during the myocardial contraction cycle. Sciences 182: 933–934, 1973; Adv Cyclic Nucl Res 5: 435–452, 1975
Wikman-Coffelt J, Sievert R, Coffelt RJ, Parmley WW: Oscillation of CAMP with the cardiac cycle. Biochim Biophys Res Commun 111: 450–455, 1983
Krause EG, Hosenfelder W: Patentschrift WPA 61 B/219887, Amt für Erfindungswesen der DDR, Berlin, 1981
Bartel S, Krause E: Assay of cyclic AMP-dependent protein kinase in canine myocardium: Effect of coronary artery ligation on the cytosolic enzyme. Biomed Biochim Acta 44: 1303–1313, 1985
Krause EG, Bartel S, Karczewski P, Lindenau KF: Cyclic nucleotides and changes in protein kinase activity ratio in the ischemic and nonischemic myocardium. Adv Myocardiol 4: 521–530, 1982
Hearse D: Myocardial cyclic AMP determinations: The importance of rapidity of sample freezing. J Mol Cell Cardiol 15: 653–657, 1983
Wollenberger A, Irmler R: Effects of adrenaline and methylisobutylxanthine on CAMP levels in cultures of beating heart cells of the newborn rat. Recent Adv Stud Cardiac Struct Metabol 12: 689–695, 1978
Potter JD, Piascik MT, Wisler PL, Robertson SP, Johnson CL: Calcium dependent regulation of brain and cardiac muscle adenylate cyclase. Ann NY Acad Sci 356: 220–231, 1980
Kakiuchi S, Yamazaki R, Teshima Y: Cyclic 3′,5′-Nucleotide Phosphodiesterase II. Two enzymes with different properties from brain. Biochim Biophys Res Commun 42: 968–974, 1971
Keely SL, Corbin JD, Park CR: Regulation of adenosine 3′,5′ monophosphate-dependent protein kinase. Regulation of the heart enzyme by epinephrine, glucagon, insulin, and 1-methyl-3-isobutylxanthine. J Biol Chem 250: 4832–4840, 1975
Namm DH, Mayer SE, Maltbie M: The role of potassium and calcium ions in the effect of epinephrine on cardiac cyclic adenosine 3′,5′-monophosphate, phosphorylase kinase and phosphorylase. Mol Pharmacol 4: 522–530, 1968
Denton RM, McCormack JG: Ca transport by mammalian mitochondria and its role in hormone action. Amer J Physiol 249: E543-E554, 1985
Krause EG, Beyerdörfer, I: Heart cycle-related activation of pyruvate dehydrogenase in the canine myocardium in vivo. J Mol Cell Cardiol 20 Suppl. V, p 54, 1988
Krause EG: Transient changes in enzyme activities and phosphorylation of phospholamban during the cardiac cycle. J Mol Cell Cardiol 20 Suppl. IV, p 20, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Krause, EG., Bartel, S., Beyerdörfer, I. et al. Transient changes in cyclic AMP and in the enzymic activity of protein kinase and phosphorylase during the cardiac cycle in the canine myocardium and the effect of propranolol. Mol Cell Biochem 89, 181–186 (1989). https://doi.org/10.1007/BF00220773
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00220773